Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

AEZS

Aeterna Zentaris Inc.

Dec 08 • 04:00PM ET

2.20

Dollar change -0.19
Percentage change -7.95	%

Healthcare • Biotechnology • Canada • NASD

Stock Detail • Compare Perf. • Options Chain • Save to Portfolio • Create Alert

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-4.81	Insider Own	0.30%	Shs Outstand	4.86M	Perf Week	5.77%
Market Cap	10.69M	Forward P/E	-	EPS next Y	-3.37	Insider Trans	0.00%	Shs Float	4.84M	Perf Month	46.30%
Income	-23.37M	PEG	-	EPS next Q	-0.97	Inst Own	0.95%	Short Float / Ratio	0.98% / 4.59	Perf Quarter	-16.98%
Sales	6.86M	P/S	1.56	EPS this Y	31.20%	Inst Trans	24.76%	Short Interest	0.05M	Perf Half Y	-22.54%
Book/sh	5.41	P/B	0.41	EPS next Y	-4.66%	ROA	-42.84%	Target Price	15.00	Perf Year	-40.46%
Cash/sh	7.98	P/C	0.28	EPS next 5Y	-	ROE	-61.74%	52W Range	1.36 - 4.00	Perf YTD	-30.82%
Dividend	-	P/FCF	-	EPS past 5Y	30.08%	ROI	-88.69%	52W High	-45.00%	Beta	1.67
Dividend %	-	Quick Ratio	9.89	Sales past 5Y	670.41%	Gross Margin	94.54%	52W Low	61.75%	ATR	0.16
Employees	21	Current Ratio	9.91	Sales Q/Q	-99.84%	Oper. Margin	-229.36%	RSI (14)	61.35	Volatility	7.31% 8.36%
Optionable	No	Debt/Eq	0.01	EPS Q/Q	-21.20%	Profit Margin	-340.56%	Rel Volume	2.07	Prev Close	2.39
Shortable	Yes	LT Debt/Eq	0.00	Earnings	Nov 09 BMO	Payout	-	Avg Volume	10.35K	Price	2.20
Recom	1.00	SMA20	17.78%	SMA50	20.99%	SMA200	-14.75%	Volume	21,393	Change	-7.95%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-19-17	Reiterated	Maxim Group	Buy	$2 → $4
May-10-17	Reiterated	H.C. Wainwright	Buy	$7.50 → $3
May-01-17	Reiterated	Maxim Group	Buy	$11 → $2
Jan-17-17	Reiterated	Maxim Group	Buy	$7 → $10
Dec-02-15	Reiterated	H.C. Wainwright	Buy	$11 → $12
Nov-24-15	Reiterated	H.C. Wainwright	Buy	$0.11 → $11
Nov-23-15	Reiterated	Maxim Group	Buy	$200 → $11
Apr-14-15	Upgrade	H.C. Wainwright	Neutral → Buy	$1.25
Nov-06-14	Downgrade	H.C. Wainwright	Buy → Neutral
Jul-17-14	Initiated	H.C. Wainwright	Buy	$3
Jan-03-13	Upgrade	MLV & Co	Hold → Buy	$5.50
Oct-09-12	Initiated	Maxim Group	Buy	$9
Apr-02-12	Downgrade	MLV & Co	Buy → Hold
Jun-07-11	Initiated	Oppenheimer	Outperform	$5.50
Apr-27-11	Reiterated	Canaccord Genuity	Speculative Buy	$2.75 → $4
Nov-29-10	Initiated	MLV Capital	Buy	$5.50
Feb-05-09	Upgrade	RBC Capital Mkts	Sector Perform → Outperform
Jun-03-08	Reiterated	Canaccord Adams	Buy	$3.20 → $2.65
Apr-14-08	Reiterated	Canaccord Adams	Buy	$4.50 → $3.20
Oct-03-07	Reiterated	Rodman & Renshaw	Mkt Outperform	$8 → $6

Show Previous Ratings

Nov-09-23 08:32AM	Aeterna Zentaris: Q3 Earnings Snapshot (Associated Press Finance)
08:00AM	Aeterna Zentaris Reports Third Quarter 2023 Financial Results (GlobeNewswire)
Oct-18-23 10:00AM	JTC Team Announces Presenting Company Line Up for the Virtual Investor Ask the CEO Conference Being Held October 24-25, 2023 (ACCESSWIRE) -7.12%
Oct-11-23 08:00AM	Aeterna Zentaris to Participate at the Virtual Investor Ask the CEO Conference (GlobeNewswire)
Sep-05-23 08:00AM	Aeterna Zentaris to Present at the H.C. Wainwright 25th Annual Global Investment Conference (GlobeNewswire)
09:40AM	Loading…
Aug-09-23 09:40AM	Aeterna Zentaris (AEZS) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
08:31AM	Aeterna Zentaris: Q2 Earnings Snapshot (Associated Press Finance)
08:05AM	Aeterna Zentaris Reports Second Quarter 2023 Financial Results (GlobeNewswire)
Jul-13-23 07:30AM	Aeterna Zentaris Outlines Progress on Development Pipeline Programs and Provides Corporate Update (GlobeNewswire)
Jul-05-23 08:45AM	Aeterna Zentaris to Participate in the Virtual Investor Summer Spotlight Series (GlobeNewswire)
Jun-14-23 04:05PM	Aeterna Zentaris Announces Results of Virtual 2023 Meeting of Shareholders (GlobeNewswire)
May-15-23 04:05PM	Aeterna Zentaris Announces Virtual 2023 Meeting of Shareholders (GlobeNewswire)
May-10-23 05:03AM	Aeterna Zentaris: Q1 Earnings Snapshot (AP Finance)
May-09-23 05:00PM	Aeterna Zentaris Reports First Quarter 2023 Financial Results (GlobeNewswire)
Apr-06-23 10:15AM	Aeterna (AEZS) Falls 5% on US Sales Halt of Growth Hormone Drug (Zacks)
07:55AM	Loading…
Apr-05-23 07:55AM	Aeterna Zentaris Provides Update on Macrilen® (Macimorelin), Reiterates Advancement of Pediatric DETECT Trial (GlobeNewswire)
Mar-23-23 09:25AM	Aeterna Zentaris (AEZS) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
08:32AM	Aeterna Zentaris: Q4 Earnings Snapshot (AP Finance)
08:05AM	Aeterna Zentaris Reports Fourth Quarter and Full Year 2022 Financial Results (GlobeNewswire)
Mar-16-23 08:05AM	Pharmanovia to Market GHRYVELIN (Macimorelin) in the European Economic Area (EEA) and UK as Diagnostic Test for Growth Hormone Deficiency (GHD) (GlobeNewswire)
Feb-23-23 09:40AM	Are Medical Stocks Lagging IDEXX Laboratories (IDXX) This Year? (Zacks)
Feb-07-23 09:40AM	Is AEterna Zentaris (AEZS) Stock Outpacing Its Medical Peers This Year? (Zacks)
Jan-17-23 12:53PM	Aeterna Zentaris Shelves Early-Stage Vaccine Programs, Including COVID-19 (Benzinga)
08:05AM	Aeterna Zentaris Provides Business Update and Outlines Key Upcoming Milestones (GlobeNewswire)
Jan-11-23 01:00PM	JTC Team to Host the Virtual Investor 2023 Companies to Watch Event on January 17th, 18th, and 19th (ACCESSWIRE)
Jan-10-23 08:05AM	Aeterna Zentaris to Present at the Virtual Investor 2023 Companies to Watch Event (GlobeNewswire)
Nov-03-22 10:15AM	Aeterna Zentaris (AEZS) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
08:05AM	Aeterna Zentaris Reports Third Quarter 2022 Financial Results (GlobeNewswire)
Aug-29-22 08:00AM	Aeterna Zentaris Set to Regain Full Rights to Macrilen (Macimorelin) in U.S. and Canada from Novo Nordisk (GlobeNewswire) -5.94%
Aug-03-22 05:30PM	Aeterna Zentaris Reports Second Quarter 2022 Financial Results and Recent Highlights (GlobeNewswire) +9.37%
10:02AM	Loading…
Jul-28-22 10:02AM	CytomX Therapeutics (CTMX) Expected to Beat Earnings Estimates: Can the Stock Move Higher? (Zacks)
Jul-18-22 05:06PM	Aeterna Zentaris Announces Effective Date of Share Consolidation (GlobeNewswire) -6.77%
Jul-15-22 04:15PM	Aeterna Zentaris Announces Shareholder Approval of Share Consolidation (GlobeNewswire)
Jul-06-22 04:05PM	Aeterna Zentaris Announces Further Adjournment of Shareholder Meeting (GlobeNewswire)
Jun-21-22 04:01PM	Aeterna Zentaris Announces Results of Annual Meeting of Shareholders (GlobeNewswire)
Jun-13-22 08:00AM	Aeterna Zentaris Achieves Proof-of-Concept for the Treatment of NMOSD with AIM Biologicals Program (GlobeNewswire)
Jun-09-22 08:00AM	Aeterna Zentaris to Present at the JMP Securities Life Sciences Conference (GlobeNewswire)
Jun-03-22 06:58AM	Here's Why We're Watching Aeterna Zentaris' (TSE:AEZS) Cash Burn Situation (Simply Wall St.)
May-25-22 08:00AM	Aeterna Zentaris Licensing Partner, Consilient Health Announces European Launch of Ghryvelin (macimorelin) for Diagnosing Adult Growth Hormone Deficiency (GlobeNewswire)
May-18-22 08:00AM	Aeterna Zentaris to Present at the H.C. Wainwright Global Investment Conference (GlobeNewswire)
May-16-22 08:00AM	Aeterna Zentaris Announces Virtual 2022 Meeting of Shareholders and Urges Shareholders to Vote in Favor of the Proposed Share Consolidation (GlobeNewswire) -22.68%
May-12-22 08:05AM	Update on Positive Pre-Clinical Results from AIM Biologicals Development Program for the Potential Treatment of Parkinsons Disease (GlobeNewswire)
May-11-22 08:05AM	Aeterna Zentaris Reports First Quarter 2022 Financial Results and Provides Business Outlook (GlobeNewswire)
May-02-22 08:25AM	UniQure (QURE) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
Apr-25-22 08:05AM	Aeterna Zentaris Abstract Accepted for Presentation at IMMUNOLOGY2022, the Annual Event of the American Association of Immunologists (GlobeNewswire)
Apr-19-22 08:05AM	Aeterna Zentaris Secures New European Patent Related to Use of Macimorelin for the Diagnosis of Growth Hormone Deficiency in Adults (GlobeNewswire)
Apr-13-22 10:45AM	JTC Team Announces Continuation of its Virtual Investor Spotlight Series with NASDAQ: AEZS, NASDAQ: CNSP, and NASDAQ: AREC (ACCESSWIRE)
Apr-12-22 08:05AM	Aeterna Zentaris to Participate at the Virtual Investor 2022 CEO Spotlight (GlobeNewswire)
Apr-11-22 08:05AM	Aeterna Zentaris Abstract Accepted for Presentation at 13th International Congress on Autoimmunity (GlobeNewswire)
Mar-29-22 08:00AM	Aeterna Zentaris Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Outlook (GlobeNewswire)
Mar-21-22 05:15PM	TELA Bio, Inc. (TELA) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
12:22PM	Aeterna Zentaris Says Enrollment In Growth Hormone Deficiency Trial To Continue Into 2023 (Benzinga)
08:05AM	Aeterna Zentaris Provides Update on Ongoing Pivotal Phase 3 DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone Deficiency (GlobeNewswire)
Mar-17-22 08:25AM	Synlogic, Inc. (SYBX) Reports Q4 Loss, Misses Revenue Estimates (Zacks)
Mar-15-22 09:15AM	ANI Pharmaceuticals (ANIP) Lags Q4 Earnings Estimates (Zacks)
Mar-10-22 07:05AM	Aeterna Zentaris Announces Expansion of Research Program with Julius-Maximilians-University Wuerzburg Aiming to Accelerate Development of Vaccine Programs (GlobeNewswire)
Mar-02-22 08:05AM	Aeterna Zentaris Announces Notice of Allowance for U.S. Patent Covering AEZS-150 for the Potential Treatment of Chronic Hypoparathyroidism (GlobeNewswire) +8.26%
Mar-01-22 09:05AM	Epizyme (EPZM) Reports Q4 Loss, Misses Revenue Estimates (Zacks)
Feb-07-22 08:05AM	Aeterna Zentaris to Present at the 2022 BIO CEO & Investor Conference (GlobeNewswire)
Feb-04-22 01:38PM	Legacy Financial Advisors, Inc. Buys iShares Core U.S. ... (GuruFocus.com)
Jan-26-22 04:05PM	Aeterna Zentaris Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule (GlobeNewswire)
08:05AM	Aeterna Zentaris Provides Business Outlook and Outlines Pipeline Priorities (GlobeNewswire)
Jan-20-22 08:05AM	Aeterna Zentaris to Present at the Virtual Investor 2022 Top Picks Conference (GlobeNewswire)
Jan-12-22 10:35AM	JTC Team to Host Virtual Investor 2022 Top Picks Conference on January 25th, 26th, and 27th (ACCESSWIRE)
Jan-05-22 08:36AM	Aeterna Zentaris to Present at the H.C. Wainwright BioConnect Conference (GlobeNewswire) -5.77%
Dec-25-21 08:31AM	Companies Like Aeterna Zentaris (TSE:AEZS) Can Afford To Invest In Growth (Simply Wall St.)
Dec-23-21 04:05PM	Aeterna Zentaris Appoints Giuliano La Fratta as Chief Financial Officer (GlobeNewswire)
Nov-04-21 04:05PM	Aeterna Zentaris Reports Third Quarter 2021 Financial Results and Provides Pipeline Program Updates (GlobeNewswire) +9.42%
Oct-21-21 07:30PM	This Isnt Sci-Fi: How AI Is About To Disrupt This $11 Trillion Industry (Oilprice.com)
Oct-20-21 07:30PM	Why A.I. Is About To Trigger The Next Great Medical Breakthrough (Oilprice.com)
Oct-01-21 12:46PM	3 Hot Penny Stocks: Why ZOM, AEZS and PROG Are Seeing Big Gains Today (InvestorPlace)
Sep-26-21 08:02AM	Aeterna Zentaris (TSE:AEZS) shareholders have endured a 82% loss from investing in the stock five years ago (Simply Wall St.)
Sep-08-21 08:00AM	Aeterna Zentaris to Present at the H.C. Wainwright 23rd Annual Global Investment Conference (GlobeNewswire)
Aug-04-21 04:05PM	Aeterna Zentaris Reports Second Quarter 2021 Financial Results and Provides Pipeline Program Updates (GlobeNewswire)
Jul-29-21 08:05AM	Aeterna Zentaris Receives Nasdaq Notification Regarding Minimum Bid Price Compliance; No Immediate Impact on Listing (GlobeNewswire) -6.38%
Jun-28-21 01:56AM	We Think Aeterna Zentaris (TSE:AEZS) Can Easily Afford To Drive Business Growth (Simply Wall St.)
Jun-13-21 02:10PM	Hedge Funds Are Buying AEterna Zentaris Inc. (AEZS) (Insider Monkey)
Jun-07-21 08:05AM	Aeterna Zentaris Engages Dr. Michael Levy to Support Development of Autoimmune and Inflammatory CNS Disorders Programs (GlobeNewswire)
Jun-03-21 08:05AM	Aeterna Zentaris Announces Final Settlement of Previously Disclosed Class-Action Lawsuit (GlobeNewswire)
May-18-21 12:30PM	Could This Be The Hottest Investment Sector For 2021? (Oilprice.com) +5.21%
May-17-21 10:12AM	Aeterna Zentaris Starts Animal Studies For Macimorelin For Amyotrophic Lateral Sclerosis (Benzinga)
08:05AM	Aeterna Zentaris Announces the Start of Preclinical Development of Macimorelin at The University of Queensland as a Potential New Treatment Option for Patients with Amyotrophic Lateral Sclerosis (ALS, Lou Gehrigs Disease) (GlobeNewswire)
May-13-21 09:33AM	Aeterna Zentaris Starts Research Study On How Well Macimorelin Works For Growth Hormone Deficiency Diagnosis (Benzinga) -5.96%
08:05AM	Aeterna Zentaris Commences Pivotal Phase 3 DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone Deficiency (GlobeNewswire)
May-10-21 08:05AM	Aeterna Zentaris to Present at the Q2 Virtual Investor Summit (GlobeNewswire)
May-06-21 08:05AM	Aeterna Zentaris Announces the Selection of a Development Candidate in the DC-PTH Program for the Potential Treatment of Primary Hypoparathyroidism (GlobeNewswire)
May-05-21 04:35PM	Aeterna Zentaris Announces Results of 2021 Annual Meeting of Shareholders (GlobeNewswire) -7.89%
08:05AM	Aeterna Zentaris Reports First Quarter 2021 Financial Results and Provides Pipeline Program Updates (GlobeNewswire)
May-03-21 08:05AM	Aeterna Zentaris Appoints Michael Teifel, Ph.D. as Senior Vice President, Non-Clinical Development and Chief Scientific Officer (GlobeNewswire)
Apr-28-21 08:05AM	Aeterna Zentaris Announces Virtual 2021 Annual Meeting of Shareholders (GlobeNewswire) +8.65%
Mar-30-21 02:23AM	Should Aeterna Zentaris (TSE:AEZS) Be Disappointed With Their 100% Profit? (Simply Wall St.)
Mar-25-21 08:05AM	Aeterna Zentaris Reports Fourth Quarter and Full Year 2020 Financial Results (GlobeNewswire) +6.36%
Mar-22-21 04:05PM	Aeterna Zentaris Regains Compliance with Nasdaq Minimum Bid Price Requirement (GlobeNewswire)
Mar-15-21 09:11AM	Aeterna Zentaris Shares Are Trading Higher On Announcing Licensing Pact For Development Of Prophylactic COVID-19 Vaccine Candidate (Benzinga) +27.97%
08:05AM	Aeterna Zentaris Announces Exclusive License Agreement and Research Contract with Julius-Maximilians-University Wuerzburg for Development of a Potential Oral Prophylactic Bacterial Vaccine Against COVID-19 (GlobeNewswire)
Mar-11-21 08:05AM	Aeterna Zentaris Continues to Demonstrate Pipeline Expansion Announces the Initiation of Its Preclinical Program for the Potential Treatment of Primary Hypoparathyroidism (GlobeNewswire) +22.77%
Feb-24-21 08:05AM	Aeterna Zentaris to Present at the H.C. Wainwright Global Life Sciences Conference (GlobeNewswire)
Feb-19-21 01:25PM	Aeterna Zentaris Announces Closing of $29.7 Million Bought Deal Offering of Common Shares (GlobeNewswire) +5.71%
Feb-16-21 10:00PM	Aeterna Zentaris Increases Previously Announced Bought Deal Offering of Common Shares to $29.7 Million (GlobeNewswire)
05:19PM	Aeterna Zentaris Announces $10.0 Million Bought Deal Offering of Common Shares (GlobeNewswire)

Aeterna Zentaris, Inc. is a specialty biopharmaceutical company, which engages in the development and commercialization of therapeutics and diagnostic tests. Its product Macimorelin, is an oral growth hormone secretagogue receptor agonist indicated for the diagnosis of Adult Growth Hormone Deficiency. The company was founded on September 12, 1990 and is headquartered in Charleston, SC.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

AEZS

Aeterna Zentaris Inc.

Upgrade your FINVIZ experience